Anthrax vaccine safety

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
引用
收藏
页码:17 / 17
页数:1
相关论文
共 50 条
  • [41] Manufacturing - Avecia to produce anthrax vaccine
    不详
    [J]. CHEMICAL WEEK, 2003, 165 (36) : 22 - 22
  • [42] Anthrax vaccine and public health policy
    Weiss, Martin Meyer
    Weiss, Peter D.
    Weiss, Joseph B.
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2007, 97 (11) : 1945 - 1951
  • [43] Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans
    Pittman, PR
    Kim-Ahn, G
    Pifat, DY
    Coonan, K
    Gibbs, P
    Little, S
    Pace-Templeton, JG
    Myers, R
    Parker, GW
    Friedlander, AM
    [J]. VACCINE, 2002, 20 (9-10) : 1412 - 1420
  • [44] Lymphocytic vasculitis associated with the anthrax vaccine:: Case report and review of anthrax vaccination
    Muñiz, AE
    [J]. JOURNAL OF EMERGENCY MEDICINE, 2003, 25 (03): : 271 - 276
  • [45] IOM deems anthrax vaccine safe, effective
    不详
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (08) : 704 - 704
  • [48] The anthrax vaccine program: An analysis of the CDC's recommendations for vaccine use
    Nass, M
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2002, 92 (05) : 715 - 721
  • [49] Characterization of the UK anthrax vaccine and human immunogenicity
    Modi, Tapasvi
    Gervais, David
    Smith, Stuart
    Miller, Julie
    Subramaniam, Shaan
    Thalassinos, Konstantinos
    Shepherd, Adrian
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 747 - 758
  • [50] HEPA/vaccine plan for indoor anthrax remediation
    Wein, LM
    Liu, YF
    Leighton, TJ
    [J]. EMERGING INFECTIOUS DISEASES, 2005, 11 (01) : 69 - 76